9999999997-14-013717.txt : 20140917 9999999997-14-013717.hdr.sgml : 20140917 20140917101653 ACCESSION NUMBER: 9999999997-14-013717 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140917 DATE AS OF CHANGE: 20140917 20140917 20140917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARCA biopharma, Inc. CENTRAL INDEX KEY: 0000907654 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 363855489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-22873 FILM NUMBER: 141106973 BUSINESS ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 BUSINESS PHONE: 720-940-2200 MAIL ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 140 CITY: WESTMINSTER STATE: CO ZIP: 80020 FORMER COMPANY: FORMER CONFORMED NAME: NUVELO INC DATE OF NAME CHANGE: 20030203 FORMER COMPANY: FORMER CONFORMED NAME: HYSEQ INC DATE OF NAME CHANGE: 19970610 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0R(#`@;V)J#3P\+TQI;F5AF4@-34O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@ M8F#R`A(,4X`$XPT@P1(()-@_`8E/V0Q,C`P[0;(,C.C$?\99?P`"#`#75@?D M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@ M("`@#0HU-"`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``(>6P94P,@` MDN5H0!9C@6(&AAL,W`R7!E+U!A9V4^/@UE;F1O8FH--#4@,"!O8FH-/#PO1FEL=&5R+T9L871E M1&5C;V1E+T9I;ORH9,4*X M(3/X].N$\T!2VA1C80V^5*DN%MY]G'O7.MFK@QN)B\IH4]KR0`Q)NF3E"OMG M;`\Y_=KV:^\/.8ZHC'Q(JF\`^E-%A&#XU/#4?7-TQ,.?0-RYSN"JAA=(P2WI M(3TNX4MWP2&K)PC$($+UG10C`AY`UG,P3B>D]YG!AIL#FTK1+WU3C6N"&IAU M]B[?Z`$Z.J0QP@GB2$3`C40(20=F',CZ$1D#QB>?+[IO*J(\IKV6GA5?:D\)ZKN>)_UES% M!OD$10$?MZ.KG*BS)3?,IJOA`;.;"KYWI^)[X.\% M?$&:^[Q8<562!C%!I>U5,:AC)$#QO1+^'A_ZI3A><4_&BJMZTXL+N47`Y?R6X7A%>"6YJS]#;B(%)8.M)&`-O.Z6W2LM]O>6O]59%1S0& M;-3_?6.$FCV.Y6/[D^/UO>P=DE0`?/N/Y?88O-P>AY/;WP(,`+D'?&0-"F5N M9'-T-M$"!;)%X2-I7/C:Q.YN_WWG$$E)=NP^;-$`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`#QTJ;;[!$>JJTY7L)YP!V(7-"+^G',$?U,<[/-`X`V!T$'=&*+.FB M'H\A.A.Z_;YF??AW)I*Q8`)R?PE%X?:([@/I+I)NZ;JXIBNJ#P=(N1C)%RWO/MJ MQ:*#)ZI,%,LKF=5H`'4()*RC6#]2@4.::W@Z)8,[2;MG+"A*G"8SK_?4AFWMLDWX M;J2$8->!?%K(FEFC%^#=FFU/X.TOY"W'=C=C15N@@/P^'#$\1PEUO!L^IYL+ M-Q2MR=+[X+-L=R:OP1-M3VI;D!KJICE=?#\CHA>+0U47;C?2S;I^0OK9ZN6: MK(VC+7-UA!HF;>H)H!TGX4#=I/5>6KHNOK$)Q-Z;<:'?'W"BA"U[H<\-&F(> MIC35/-;(!>S-(_]:)][YT#F25<[$?G6"4\Y/7`'%(X]B2NB;^ZI[8':5AN*AY M]5J=?TOE[3^OSSW(6KS`$_S8]=56`;8#""0_ZMNH&;-&B0".A+*QK_)VZM\Q M%-<.:-NZ>+N1)%>9_99[PTXWY=&(^<_-7)7YJ3PU\=X(MT>2G";9__+Z6KB\ M#WZ4[#&.\4K<8$24>`_;'XTQX+G1:Y\IJ2I2RP;Q!^6^@S-]RIU^(C;I@9'X MZYDYK,W<[+:-!D[J'BSR=SCR/G`/IH_4ARU_I<*+T1Y"M:$9@J$AUZCH>.;G MWO#3*"H.0^2R.OM'@`$`3A_@A`T*96YDCBY,HDP,"0FU=2Y![D&!D1&:7`?IZ!C8&9`0P2DXL+'`," M?$#LO/R\5`8,\.T:`R.(OJP+,@M3'B]@32XH*@'2!X#8*"6U.!E(?P'BS/*2 M`J`X8P*0+9*4#6:#U(EDAP0Y`]D=0#9?26H%2(S!.;^@LB@S/:-$P=#2TE+! M,24_*54AN+*X)#6W6,$S+SF_J""_*+$D-06H%FH'"/"[%R56*K@GYN8F*ACI M&9'H^2'Q*93_0GE51014DHD12):A*NR!<46$2D% M1$FI0E14%P@`!%%375;$!=4UPH,'##,R)IK!1:J)`PY`#T=D],0E,C$M)^(P M3L@0B&MD%3$>1BA*$O`$IPAX4F)L\*3&X.`%-`EXH?0DX(6::1YH_AH!+\9` M`EY,D2XNW`T^O:"MVS1C[J;]F#,T_+VQSB_337XE[[;]8_[2#%`T=^Q?A^QV MTW@Z+&W;OI]6JQEY"VMHF*TM(1I!(VJ4&I5&TEC`L[4EE,)*8:6P4E@IK!16 M"BN%E2)*$:6(4D0IHA11BBA%E")*D85RYS:T5-W.[?)!/W!]>GJ^+>8G,GFG%RU^WQ-&;WL6V.8_/TMAS[X:H9?BT_=??X;W;K M^><:$G^O/G>/;9=W#PU$G[N_GJ9Y3T^!_/9'[D_3>7GZ_GP8V^%M.>3QSXT] M+O)#_^(N,=JW[CZ/;Z35ZG^ZL^59%[BY\],^4@CG.]SH"\5;MJIL5L6L!K,: MS6II5BNSFLQJ;=MX1Y9MR]NZO.W+V\*\;G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U+C(M8S`P,2`V,RXQ M,SDT,SDL(#(P,3`O,#DO,C&UP.DUE=&%D871A1&%T93XR M,#$T+3`Y+3$W5#$P.C$U.C,T+3`T.C`P/"]X;7`Z365T861A=&%$871E/@H@ M("`@("`@("`\>&UP.D-R96%T;W)4;V]L/D%C&UP.D-R96%T;W)4;V]L/@H@("`@("`\+W)D9CI$97-C M&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N,"]M;2\B/@H@("`@("`@("`\>&UP34TZ1&]C=6UE;G1)1#YU=6ED M.C(V96%B968Y+65E83DM-&,Q82TY,S0V+3!F9#@X.#!A865E,#PO>&UP34TZ M1&]C=6UE;G1)1#X*("`@("`@("`@/'AM<$U-.DEN&UL;G,Z9&,](FAT M='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A=6QT(B\^"B`@("`@("`@("`@ M(#PO"UD969A=6QT(B\^"B`@("`@("`@ M("`@(#PO&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI02`Q,"XP/"]P9&8Z4')O9'5C97(^"B`@("`@("`@(#QP9&8Z2V5Y M=V]R9',O/@H@("`@("`\+W)D9CI$97-C&UL;G,Z<&1F M>#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&9X+S$N,R\B/@H@("`@("`@("`\ M<&1F>#I3;W5R8V5-;V1I9FEE9#Y$.C(P,30P.3$W,30Q-3`Y/"]P9&9X.E-O M=7)C94UO9&EF:65D/@H@("`@("`@("`\<&1F>#I#;VUP86YY/E-E8W5R:71I M97,@86YD($5X:&%N9V4@0V]M;6ES#I#;VUP86YY/@H@("`@ M("`@("`\<&1F>#I#;VUM96YT#I#;VUM96YT M7!E M+T]B:E-T;3X^3J8VU&9DDZ/Y[LR+BP=MC^-[W&*,!8;5J-R6?6%1)3;OERX5B3NJ))`6. MH*?X?7VW<5`'AH\:DFK:'?O_G.;7 MN1?VQ5&5>NYI5,)#Z,7*,%KK%PHZ+"I3^E5RN8X\AOY%J MUNLO`08`(NE8K0T*96YDF4@-#(O5'EP92]84F5F+U=; M,2`R(#%=/CYS=')E86T-"FC>8F(``B9&?FT&)@:F%"`A>`E(,/2!N.9`B3NW M05P&QB%`,-T'$HP,``$&`!X2!5L-"F5N9'-T